Is zoledronic acid contraindicated in renal failure?
All bisphosphonates have registration “warnings” for use in patients with severe renal impairment (CrCl <30 or <35 mL/min). IV zoledronic acid has included a “contraindication” in the registration labels for patients with eGFR <35 mL/min (2).
Are bisphosphonates safe in renal failure?
Because of their urinary elimination, bisphosphonates must be carefully administered in chronic kidney disease (CKD) patients. In spite of this, bisphosphonates can safely be used in all CKD stages, including dialysis and kidney transplant.
Is zoledronic acid nephrotoxic?
Our data confirm the previously reported risk factors for zoledronic acid-associated nephrotoxicity such as advanced cancer, multiple myeloma, preexisting renal failure, diabetes, hypertension, and concomitant use of nephrotoxic drugs.
Why are bisphosphonates contraindicated in renal failure?
Bisphosphonates, which are excreted via the kidneys, may accumulate in patients with diminished renal function, and toxicity may occur. There have been several reports of acute renal toxicity following bisphosphonate treatment.
Is Reclast safe for kidneys?
Reclast should be used with caution in this population. The risk of acute renal failure may increase with underlying renal disease and dehydration secondary to fever, sepsis, gastrointestinal losses, diuretic therapy, etc. The risk of developing renal failure in patients with renal impairment also increases with age.
Does zoledronic acid affect creatinine?
In patients with an estimated creatinine clearance between 30 and 35ml/min, five patients in the group treated with 5mg of zoledronic acid had an increase in serum creatinine >0.5mg/100ml compared with one patient in the placebo group.
When are bisphosphonates contraindicated?
Avoid oral bisphosphonates in patients with esophageal disorders such as achalasia, esophageal stricture, esophageal varices, Barrett’s esophagus, inability to stand or sit upright for at least 30 minutes, history of bariatric surgery (Roux-en-Y gastric bypass).
Can Reclast damage kidneys?
1, 2011 the U.S. Food and Drug Administration (FDA) warned doctors and patients that Reclast may cause severe kidney problems. These kidney problems can lead to kidney failure, the need for kidney dialysis, and could be life threatening.
Does alendronic acid affect kidneys?
have low calcium levels in your blood – alendronic acid sometimes causes low blood calcium, so your calcium levels could become even lower. have kidney problems.
How is kidney disease treated with osteoporosis?
Bone metabolic abnormalities in patients with CKD include osteoporotic elements besides renal osteodystrophy. With the advent of novel therapeutic agents for osteoporosis such as denosumab and the recombinant parathyroid hormone teriparatide, it has become practicable to treat osteoporosis even in CKD patients.
Are bisphosphonates hard on kidneys?
Nevertheless in the doses that are registered for the management of postmenopausal osteoporosis (PMO), oral bisphosphonates have never been shown to adversely affect the kidney, even (in post-hoc analysis of clinical trial data) down to estimated glomerular filtration rates of 15 ml/min.
Is Reclast hard on your kidneys?
What are the long term side effects of zoledronic acid?
Blurred vision or other change in vision.
What medication is safe to take for osteoporosis if you have chronic kidney disease?
In patients with chronic kidney disease (CKD) stages 2 [to] 3, post hoc analyses suggest that bisphosphonates, raloxifene, denosumab, or teriparatide may be effective for fracture prevention.
Is alendronate safe for kidneys?
To minimize the risk of chronic kidney disease (CKD) progressing to end-stage renal disease (ESRD), such osteoporosis medications as alendronate (Fosamax) and ibandronate (Boniva) are contraindicated in individuals whose glomerular filtration rate (GFR) is <30%.
Is teriparatide safe in CKD?
Teriparatide (recombinant 1–34 N-terminal sequence of human parathyroid hormone) for the treatment of osteoporosis should be prescribed with caution in patients with severe stages of chronic kidney disease (CKD).
Is zoledronic acid safe for patients with renal failure?
Zoledronic acid is associated with reports of renal impairment and renal failure, especially in patients with pre-existing renal dysfunction or other risk factors. The product information for Zometa already contains strong warnings and precautions regarding renal impairment and renal failure.
What is the prevalence of zoledronic acid in the US?
Overall, these three groups account for 2.8%, 3.7%, and 0.13% of the U.S. adult population, respectively, and the three groups combined comprise 13.4 million people. Many of these people develop cancer with bone metastases and become candidates for zoledronic acid treatment.
Does prolongation of the 15-minute zoledronic acid infusion time improve outcome?
Prolongation of the 15-minute infusion time might offer a safer delivery of i.v. administered zoledronic acid, preventing, or at least mitigating, adverse renal outcome.
What are the possible adverse effects of intravenous zoledronic acid?
Intravenous zoledronic acid: adverse effects on renal function. Zoledronic acid is associated with reports of renal impairment and renal failure, especially in patients with pre-existing renal dysfunction or other risk factors.